AAGH: America Great Health Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 55.09
Enterprise Value ($M) 57.43
Book Value ($M) -4.87
Book Value / Share -0.00
Price / Book -11.30
NCAV ($M) -4.94
NCAV / Share -0.00
Price / NCAV -11.15

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -2.92
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.04
Current Ratio 0.08

Balance Sheet (mrq) ($M)
Current Assets 0.27
Assets 0.33
Liabilities 5.21
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-06-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-23 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-08 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 2)
2024-02-08 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2023-11-17 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-11-16 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1)
2023-10-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)

Similar Companies
AAVXF – ABIVAX Société Anonyme ABCZF – Abcam Limited


Financial data and stock pages provided by
Fintel.io